| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/02/2005 | EP1077698B1 Metabolites of ecteinascidin 743 |
| 03/02/2005 | EP1070067B1 Cytotoxic alkaloid derivatives including asmarine a and b isolated from a sponge |
| 03/02/2005 | EP1042279B1 Substituted beta-alanines |
| 03/02/2005 | EP1034207B1 BIODEGRADABLE LOW MOLECULAR WEIGHT TRIBLOCK POLY(LACTIDE-co-GLYCOLIDE) POLYETHYLENE GLYCOL COPOLYMERS HAVING REVERSE THERMAL GELATION PROPERTIES |
| 03/02/2005 | EP0871448B1 Aryl and heteroaryl quinazoline compounds which inhibit csf-1r receptor tyrosine kinase |
| 03/02/2005 | EP0844873B1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 03/02/2005 | EP0824530B1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 03/02/2005 | EP0799311B1 Human chemokine beta-9 |
| 03/02/2005 | CN1589279A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/02/2005 | CN1589271A Fused heterocyclic succinimide compounds and analogs thereof as modulators of nuclear hormone receptor function |
| 03/02/2005 | CN1589268A Substituted benzopyrans compounds as selective estrogen receptor-beta agonists |
| 03/02/2005 | CN1589264A Method for the treatment of malignant tumours |
| 03/02/2005 | CN1589262A Cyanoguanidine prodrugs |
| 03/02/2005 | CN1589260A Heterocyclic compounds and methods of use thereof |
| 03/02/2005 | CN1589258A Novel beta -phenyl- alpha -oxysubstituted propionic derivatives: process for their preparation and their use in the preparation of pharmaceutically important compounds |
| 03/02/2005 | CN1589254A Double esters |
| 03/02/2005 | CN1589157A Inclusion complex of taxol with 2-hydroxypropyl-beta-cyclodextrin |
| 03/02/2005 | CN1589151A Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 03/02/2005 | CN1589149A Reduced toxicity cisplatin formulations and methods for using the same |
| 03/02/2005 | CN1589145A αv整联蛋白受体拮抗剂 αv integrin receptor antagonists |
| 03/02/2005 | CN1589143A Method for cancer therapy |
| 03/02/2005 | CN1589142A Production of pure stereoisomers of tricyclo[5.2.1.02.6]-dec-9-yl xanthogenate and medicaments therefrom |
| 03/02/2005 | CN1589138A Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy |
| 03/02/2005 | CN1589135A Small molecule antagonists of BCL-2 family proteins |
| 03/02/2005 | CN1587411A Preparation of KTV series products for inhibiting tumor cell growth and use |
| 03/02/2005 | CN1587406A SiRNA double chain for inhibiting bc 1-2 gen expression and use |
| 03/02/2005 | CN1587279A Process for preparing tuckahoe mycelium extracellular polysacchride with anti-tumor activity |
| 03/02/2005 | CN1587265A 10-alkoxy camptothecine derivative and its preparing method and use |
| 03/02/2005 | CN1587263A Novel pyrimidyl sulfamide compounds with anti-tumor activity and their salts |
| 03/02/2005 | CN1587261A Imidazole-2-ketone compound and its preparing method and use |
| 03/02/2005 | CN1586625A Combined article for tumor display and treatment and its preparing method |
| 03/02/2005 | CN1586624A Water soluble chitose intervention embolism chemical therapeutic medicine slow release gel microball |
| 03/02/2005 | CN1586619A Natural lycopene compound oil preparation and capsule and its preparing method and use |
| 03/02/2005 | CN1586614A Self-emulsified aromatic turmeric oil soft capsule and its preparing method |
| 03/02/2005 | CN1586604A Zedoary injection preparation and its preparing method |
| 03/02/2005 | CN1586599A Medicinal preparation containing brucea fruit oil |
| 03/02/2005 | CN1586589A Ginseng stem and leaf total saponin oral disintegration tablet and its preparing method |
| 03/02/2005 | CN1586575A Medicine decoction for benifiting qi, tonifying blood and resisting cancer |
| 03/02/2005 | CN1586544A Medicinal wine and its producing method |
| 03/02/2005 | CN1586538A Chinese medicinal powder for mainly treating stomach tumor |
| 03/02/2005 | CN1586535A Liuweidihuang effervescent tablet and its preparing method |
| 03/02/2005 | CN1586506A Jiangbai oral liquid |
| 03/02/2005 | CN1586500A Disodium cantharidinate injection for treating tumor and its preparing method |
| 03/02/2005 | CN1586476A Use of compound and its derivatives in preparing medicine for treating cancer |
| 03/02/2005 | CN1191355C Process for preparing fowl paralysis virus using cntinuous avian cell line |
| 03/02/2005 | CN1191276C Humanized antibodies and method for forming same |
| 03/02/2005 | CN1191268C Antisense oligonucleitde structure and use using serine/threonine kinase AIM-1 gene as target |
| 03/02/2005 | CN1191267C Antisense oligonucleotide structure and use using serine/threonine kinase P[K] gene as target |
| 03/02/2005 | CN1191257C Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them |
| 03/02/2005 | CN1191252C 3-position substituted quinolone derivativers and its use in pharmacy |
| 03/02/2005 | CN1191239C Pyrazole derivatives for the treatment of viral diseases |
| 03/02/2005 | CN1191237C Substituted caprolactam carbonates and ethers and their use as anti-tumor agents |
| 03/02/2005 | CN1191236C Substituted 6,6-Hetero-dicycloderivative |
| 03/02/2005 | CN1191094C Targeted liposome gene delivery |
| 03/02/2005 | CN1191090C Use of enterobaterium protein ompA associated with antigen for generating antiviral, aniparsitic or antitumoral cytotoxic response |
| 03/02/2005 | CN1191089C Use of an OmpA enterobacteriumprotein associated with the ELAGIGILTV peptide for treating melanomal |
| 03/02/2005 | CN1191072C High-molecular medicine resisting tumor metastasis and its preparing process |
| 03/02/2005 | CN1191067C Lipid composition of high non-soluble platinum matches and lipid body |
| 03/02/2005 | CN1191064C Medicinal composition containing phenylacetylgluta-mine, phenylacetylisoglutamize, and/or their derivatices |
| 03/01/2005 | US6861530 Piperidine derivatives |
| 03/01/2005 | US6861524 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 03/01/2005 | US6861446 C7 heterosubstituted acetate taxane compositions |
| 03/01/2005 | US6861445 3-Substituted-3-(substitutedsulfonyl or sulfanyl)pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase |
| 03/01/2005 | US6861441 (4(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo(f)isoindol-2-yl) phenyl)acetic acid |
| 03/01/2005 | US6861436 Useful against multidrug resistant cancer cells |
| 03/01/2005 | US6861435 3-(amino-imino-methyl)benzyl derivatives with an amide -n-sulfonylamido on the methyl of the benzyl |
| 03/01/2005 | US6861431 Detoxification of cells, tissues |
| 03/01/2005 | US6861430 β-carboline derivatives and its pharmaceutical use against depression and anxiety |
| 03/01/2005 | US6861429 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors |
| 03/01/2005 | US6861422 Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| 03/01/2005 | US6861419 Substituted 1, 4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/01/2005 | US6861418 Modulating protein kinase signal transduction; anticancer agents |
| 03/01/2005 | US6861417 Such as 2-(4-fluorophenyl)-3-(pyridin-4-yl)pyrazine for treating cytokine mediated diseases such as psoriatic arthritis |
| 03/01/2005 | US6861409 Compounds for use in the dtreatment of growth metabolic disorders |
| 03/01/2005 | US6861408 Therapeutic anti-melanoma compounds |
| 03/01/2005 | US6861406 Use of peptides or small molecules in treatment of disease, in high-throughput screening, in use of metal-binding peptides derived from sequences present in CD74-homology domain of insulin-like growth factor |
| 03/01/2005 | US6861076 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 03/01/2005 | US6861044 Radioiodinated sulfonated phenols and process therefore |
| 03/01/2005 | CA2390110C Modular transport systems for molecular substances and production and use thereof |
| 02/24/2005 | WO2005017151A1 End-deficient mutant of ip3 receptor protein inducing apoptosis |
| 02/24/2005 | WO2005016979A1 Etherified carbamate functional copolymers of isobutylene type monomers, and their use in curable compositions |
| 02/24/2005 | WO2005016970A2 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 02/24/2005 | WO2005016928A1 Imidazopyridine derivatives |
| 02/24/2005 | WO2005016926A1 Pyrido [3,4-d] pyrimidine derivatives as matrix metalloproteinase-13 inhibitors |
| 02/24/2005 | WO2005016920A1 Pyrrole compositions useful as inhibitors of c-met |
| 02/24/2005 | WO2005016919A1 Aminopyrones and their use as atm inhibitors |
| 02/24/2005 | WO2005016911A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | WO2005016909A1 Substituted thiophenes and uses thereof |
| 02/24/2005 | WO2005016859A2 Proteasome inhibitors and methods of using the same |
| 02/24/2005 | WO2005016382A1 Antibodies to c-met |
| 02/24/2005 | WO2005016380A1 Methods of therapy for chronic lymphocytic leukemia |
| 02/24/2005 | WO2005016374A1 Regulation of urokinase receptor expression by phosphoglycerate kinase |
| 02/24/2005 | WO2005016369A1 Use of a vegf antagonist in combination with radiation therapy |
| 02/24/2005 | WO2005016354A1 Diflunisal for the treatment of cancer |
| 02/24/2005 | WO2005016347A1 Dosing schedule for erbb2 anticancer agents |
| 02/24/2005 | WO2005009338A3 Method of inhibiting atf/creb and cancer cell growth and pharmaceutical compositions for same |
| 02/24/2005 | WO2005005431A3 7-polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups |
| 02/24/2005 | WO2005002494A3 Pharmaceutical active ingredient to combat prostatic cancer |
| 02/24/2005 | WO2004113388A3 Anti alpha - folate - receptor - tetramer antibodies |
| 02/24/2005 | WO2004099247A3 Synthetic gene encoding human carcinoembryonic antigen and uses thereof |